Abstract
The use of PLGA in the pharmaceutical industry has only increased as we move towards more and more advanced delivery carrier systems. The qualities of PLGA like biocompatibility, biodegradability and a tunable degradation and drug release has only helped in keeping up the release requirements desired for various delivery platforms. Fine-tuning the release and degradation rate is gaining more and more attention as researchers keep pushing the boundaries of novel delivery carriers. Various experiments are being performed to understand the degradation behavior of PLGA under various physiological and process-related conditions. The understanding of these parameters has helped formulate various ways in which one can fine-tune the properties that can lead to the release of active ingredients encapsulated within. Various techniques have been tried and tested including changes like chemical modification, physical blending and surface modifications and have found to be effective means of release modulation in delivery systems like parenteral, orals, topicals and tissue engineering scaffolds. In this review, all these experiments and implications thereon have been discussed in detail.
Keywords: PLGA, acid capped, degradation, tissue engineering, erosion, matrix.
Current Drug Delivery
Title:Effect of Modifications in Poly (Lactide-co-Glycolide) (PLGA) on Drug Release and Degradation Characteristics: A Mini Review
Volume: 18 Issue: 10
Author(s): Sweta Singh*Prabha Singha
Affiliation:
- Department of Pharmaceutics, Dr Bhanuben Nanavati College of Pharmacy, Vile Parle (W), Mumbai,India
Keywords: PLGA, acid capped, degradation, tissue engineering, erosion, matrix.
Abstract: The use of PLGA in the pharmaceutical industry has only increased as we move towards more and more advanced delivery carrier systems. The qualities of PLGA like biocompatibility, biodegradability and a tunable degradation and drug release has only helped in keeping up the release requirements desired for various delivery platforms. Fine-tuning the release and degradation rate is gaining more and more attention as researchers keep pushing the boundaries of novel delivery carriers. Various experiments are being performed to understand the degradation behavior of PLGA under various physiological and process-related conditions. The understanding of these parameters has helped formulate various ways in which one can fine-tune the properties that can lead to the release of active ingredients encapsulated within. Various techniques have been tried and tested including changes like chemical modification, physical blending and surface modifications and have found to be effective means of release modulation in delivery systems like parenteral, orals, topicals and tissue engineering scaffolds. In this review, all these experiments and implications thereon have been discussed in detail.
Export Options
About this article
Cite this article as:
Singh Sweta*, Singha Prabha, Effect of Modifications in Poly (Lactide-co-Glycolide) (PLGA) on Drug Release and Degradation Characteristics: A Mini Review, Current Drug Delivery 2021; 18 (10) . https://dx.doi.org/10.2174/1567201818666210510165938
DOI https://dx.doi.org/10.2174/1567201818666210510165938 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer
The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effect of Probiotics Supplementation on Maternal-Fetal Care
Current Women`s Health Reviews CoFe2O4-MWCNTs Modified Screen Printed Carbon Electrode Coupled with Magnetic CoFe2O4-MWCNTs Based Solid Phase Microextraction for the detection of Bisphenol A
Current Nanoscience Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents Acknowledgements to Reviewers:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Evaluating Quinacrine as a Potential Amyloid Imaging Compound: Studies on Hen Egg White Lysozyme as Model System
Protein & Peptide Letters Microarrays and the Genetic Analysis of Brain Tumors
Current Genomics Quantitative Gait Disturbances in Older Adults with Cognitive Impairments
Current Pharmaceutical Design Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile
Current Cancer Drug Targets Biology of Cox-2: An Application in Cancer Therapeutics
Current Drug Targets Nano-encapsulation of Proteins and Peptides
Current Nanomaterials Capillary Electrophoresis with Mass Spectrometry: Applications to Metabolomic Analysis
Current Metabolomics Immunoglobulin Free Light Chains in Immune Responses
Current Immunology Reviews (Discontinued) "Take and Run" and "Take and Hold" Therapeutical Electromagnetic Field Application Modalities in Physiotherapy: Some Clinically Significant Pathways of Action
Current Chemical Biology The Relationship Between the Serotonin Metabolism, Gut-Microbiota and the Gut-Brain Axis
Current Drug Metabolism The Impact of IL-17 in Atherosclerosis
Current Medicinal Chemistry Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis
Current Vascular Pharmacology Neuronal Differentiation of Neural Progenitor Cells by Intracellular Delivery of Synthetic Oligopeptide Derived from Von Hippel-Lindau Protein
Protein & Peptide Letters Cannabinoids and Neuropathic Pain
Mini-Reviews in Medicinal Chemistry SIRT1 as a Therapeutic Target in Diabetic Complications
Current Medicinal Chemistry Isoforms of Vitamin E Differentially Regulate Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets